Overview This page contains the latest trade data of Vaccines, blood, antisera, toxins and cultures. In 2020, Vaccines, blood, antisera, toxins and cultures were the world's 11th most traded product, with a total trade of $219B. Between 2019 and 2020 the exports of Vaccines, blood, antisera, toxins and cultures grew by 12.4%, from $195B to $219B. Trade in Vaccines, blood, antisera, toxins and cultures represent 1.31% of total world trade.
Vaccines, blood, antisera, toxins and cultures are a part of Pharmaceutical products. They include Antisera and other blood fractions, Vaccines, human use, Blood, toxins, cultures, medical use, nes, Vaccines, veterinary use, except foot and mouth, and Vaccines, foot and mouth disease, veterinary use.
Exports In 2020 the top exporters of Vaccines, blood, antisera, toxins and cultures were Germany ($34.1B), Ireland ($33B), Switzerland ($30.2B), United States ($29.8B), and Belgium ($21.3B).
Imports In 2020 the top importers of Vaccines, blood, antisera, toxins and cultures were United States ($44.9B), Germany ($25.5B), Belgium ($16.5B), Switzerland ($11.8B), and Netherlands ($11.6B).
Tariffs In 2018 the average tariff for Vaccines, blood, antisera, toxins and cultures was 1.83%, making it the 1251st lowest tariff using the HS4 product classification.
Ranking Vaccines, blood, antisera, toxins and cultures ranks 112th in the Product Complexity Index (PCI).
Description Human blood is used to provide oxygen and nutrients to the tissues and to carry away waste products from the tissues. Animal blood prepared for therapeutic, prophylactic or diagnostic uses is used to study blood-borne diseases and to provide antibodies that are used in the diagnosis of diseases. Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, are used in the diagnosis of diseases. Vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products are used in the prevention and treatment of diseases.